This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2011 Jun 8;103(11):841-4.

doi: 10.1093/jnci/djr170. Epub 2011 May 19.

Microsatellite instability, prognosis and drug sensitivity of stage II and III colorectal cancer: more complexity to the puzzle

Sabine Tejpar, Zacharenia Saridaki, Mauro Delorenzi, Fred Bosman, Arnaud D Roth

PMID: 21597023
DOI: 10.1093/jnci/djr170

Editorial

Microsatellite instability, prognosis and drug sensitivity of stage II and III colorectal cancer: more complexity to the puzzle

Sabine Tejpar et al. J Natl Cancer Inst. 2011.

. 2011 Jun 8;103(11):841-4.

doi: 10.1093/jnci/djr170. Epub 2011 May 19.

Authors

Sabine Tejpar, Zacharenia Saridaki, Mauro Delorenzi, Fred Bosman, Arnaud D Roth

PMID: 21597023
DOI: 10.1093/jnci/djr170

No abstract available

PubMed Disclaimer

Comment on

DNA mismatch repair status and colon cancer recurrence and survival in clinical trials of 5-fluorouracil-based adjuvant therapy.
Sinicrope FA, Foster NR, Thibodeau SN, Marsoni S, Monges G, Labianca R, Kim GP, Yothers G, Allegra C, Moore MJ, Gallinger S, Sargent DJ. Sinicrope FA, et al. J Natl Cancer Inst. 2011 Jun 8;103(11):863-75. doi: 10.1093/jnci/djr153. Epub 2011 May 19. J Natl Cancer Inst. 2011. PMID: 21597022 Free PMC article.

Similar articles

The efficacy of adjuvant chemotherapy with 5-fluorouracil in colorectal cancer depends on the mismatch repair status.
Jover R, Zapater P, Castells A, Llor X, Andreu M, Cubiella J, Balaguer F, Sempere L, Xicola RM, Bujanda L, Reñé JM, Clofent J, Bessa X, Morillas JD, Nicolás-Pérez D, Pons E, Payá A, Alenda C; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Jover R, et al. Eur J Cancer. 2009 Feb;45(3):365-73. doi: 10.1016/j.ejca.2008.07.016. Epub 2008 Aug 21. Eur J Cancer. 2009. PMID: 18722765
Microsatellite instability as a marker of prognosis and response to therapy: a meta-analysis of colorectal cancer survival data.
Guastadisegni C, Colafranceschi M, Ottini L, Dogliotti E. Guastadisegni C, et al. Eur J Cancer. 2010 Oct;46(15):2788-98. doi: 10.1016/j.ejca.2010.05.009. Epub 2010 Jun 4. Eur J Cancer. 2010. PMID: 20627535 Review.
Biologic behavior of microsatellite-unstable colorectal cancer and treatment with 5-fluorouracil.
Niv Y. Niv Y. Isr Med Assoc J. 2005 Aug;7(8):520-4. Isr Med Assoc J. 2005. PMID: 16106779 Review.
Role of microsatellite instability in the management of colorectal cancers.
Buecher B, Cacheux W, Rouleau E, Dieumegard B, Mitry E, Lièvre A. Buecher B, et al. Dig Liver Dis. 2013 Jun;45(6):441-9. doi: 10.1016/j.dld.2012.10.006. Epub 2012 Nov 26. Dig Liver Dis. 2013. PMID: 23195666 Review.
Mismatch repair status in the prediction of benefit from adjuvant fluorouracil chemotherapy in colorectal cancer.
Jover R, Zapater P, Castells A, Llor X, Andreu M, Cubiella J, Piñol V, Xicola RM, Bujanda L, Reñé JM, Clofent J, Bessa X, Morillas JD, Nicolás-Pérez D, Payá A, Alenda C; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Jover R, et al. Gut. 2006 Jun;55(6):848-55. doi: 10.1136/gut.2005.073015. Epub 2005 Nov 18. Gut. 2006. PMID: 16299036 Free PMC article.

See all similar articles

Cited by

Outcome of Mismatch Repair-Deficient Metastatic Colorectal Cancer: The Mayo Clinic Experience.
Jin Z, Sanhueza CT, Johnson B, Nagorney DM, Larson DW, Mara KC, Harmsen WC, Smyrk TC, Grothey A, Hubbard JM. Jin Z, et al. Oncologist. 2018 Sep;23(9):1083-1091. doi: 10.1634/theoncologist.2017-0289. Epub 2018 Apr 19. Oncologist. 2018. PMID: 29674439 Free PMC article.
A molecular signature for the prediction of recurrence in colorectal cancer.
Wang L, Shen X, Wang Z, Xiao X, Wei P, Wang Q, Ren F, Wang Y, Liu Z, Sheng W, Huang W, Zhou X, Du X. Wang L, et al. Mol Cancer. 2015 Feb 3;14(1):22. doi: 10.1186/s12943-015-0296-2. Mol Cancer. 2015. PMID: 25645394 Free PMC article.
Applying public health screening criteria: how does universal newborn screening compare to universal tumor screening for Lynch syndrome in adults with colorectal cancer?
Cragun D, DeBate RD, Pal T. Cragun D, et al. J Genet Couns. 2015 Jun;24(3):409-20. doi: 10.1007/s10897-014-9769-5. Epub 2014 Oct 18. J Genet Couns. 2015. PMID: 25323653 Free PMC article.
CHFR silencing or microsatellite instability is associated with increased antitumor activity of docetaxel or gemcitabine in colorectal cancer.
Pelosof L, Yerram SR, Ahuja N, Delmas A, Danilova L, Herman JG, Azad NS. Pelosof L, et al. Int J Cancer. 2014 Feb 1;134(3):596-605. doi: 10.1002/ijc.28390. Epub 2013 Aug 24. Int J Cancer. 2014. PMID: 23873170 Free PMC article.
Colorectal cancer molecular profiling: from IHC to NGS in search of optimal algorithm.
Furtado LV, Samowitz WS. Furtado LV, et al. Virchows Arch. 2017 Aug;471(2):235-242. doi: 10.1007/s00428-017-2153-8. Epub 2017 May 27. Virchows Arch. 2017. PMID: 28551725 Review.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information